NVWM LLC’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.04M | Buy |
3,303
+55
| +2% | +$55.8K | 0.68% | 36 |
|
|
2025
Q4 | $3.49M | Sell |
3,248
-59
| -2% | -$56.4K | 0.76% | 33 |
|
|
2025
Q3 | $2.52M | Sell |
3,307
-1,616
| -33% | -$1.2M | 0.57% | 47 |
|
|
2025
Q2 | $3.84M | Buy |
4,923
+136
| +3% | +$106K | 0.93% | 22 |
|
|
2025
Q1 | $3.95M | Sell |
4,787
-138
| -3% | -$115K | 1.05% | 21 |
|
|
2024
Q4 | $3.8M | Sell |
4,925
-47
| -0.9% | -$38.9K | 0.96% | 27 |
|
|
2024
Q3 | $4.41M | Sell |
4,972
-120
| -2% | -$108K | 1.12% | 19 |
|
|
2024
Q2 | $4.61M | Sell |
5,092
-162
| -3% | -$130K | 1.23% | 14 |
|
|
2024
Q1 | $4.09M | Sell |
5,254
-192
| -4% | -$137K | 1.12% | 16 |
|
|
2023
Q4 | $3.17M | Sell |
5,446
-281
| -5% | -$164K | 0.95% | 27 |
|
|
2023
Q3 | $3.08M | Sell |
5,727
-220
| -4% | -$113K | 1.01% | 22 |
|
|
2023
Q2 | $2.79M | Sell |
5,947
-513
| -8% | -$215K | 0.91% | 24 |
|
|
2023
Q1 | $2.22M | Buy |
6,460
+44
| +0.7% | +$14.8K | 0.74% | 36 |
|
|
2022
Q4 | $2.35M | Sell |
6,416
-328
| -5% | -$116K | 0.85% | 25 |
|
|
2022
Q3 | $2.18M | Buy |
6,744
+2,476
| +58% | +$784K | 0.87% | 23 |
|
|
2022
Q2 | $1.38M | Sell |
4,268
-7
| -0.2% | -$2.1K | 0.54% | 58 |
|
|
2022
Q1 | $1.23M | Buy |
4,275
+301
| +8% | +$77.5K | 0.39% | 85 |
|
|
2021
Q4 | $1.1M | Buy |
3,974
+360
| +10% | +$91.3K | 0.34% | 106 |
|
|
2021
Q3 | $835K | Sell |
3,614
-937
| -21% | -$231K | 0.3% | 135 |
|
|
2021
Q2 | $1.04M | Buy |
4,551
+16
| +0.4% | +$3.21K | 0.38% | 96 |
|
|
2021
Q1 | $847K | Buy |
4,535
+277
| +7% | +$54.2K | 0.34% | 113 |
|
|
2020
Q4 | $718K | Sell |
4,258
-538
| -11% | -$80.3K | 0.3% | 119 |
|
|
2020
Q3 | $710K | Buy |
4,796
+548
| +13% | +$84.8K | 0.33% | 99 |
|
|
2020
Q2 | $697K | Buy |
4,248
+29
| +0.7% | +$4.45K | 0.38% | 84 |
|
|
2020
Q1 | $585K | Buy |
4,219
+484
| +13% | +$66.5K | 0.41% | 73 |
|
|
2019
Q4 | $491K | Sell |
3,735
-117
| -3% | -$13.6K | 0.29% | 108 |
|
|
2019
Q3 | $431K | Buy |
3,852
+148
| +4% | +$16.5K | 0.26% | 125 |
|
|
2019
Q2 | $410K | Sell |
3,704
-3,322
| -47% | -$391K | 0.25% | 134 |
|
|
2019
Q1 | $912K | Buy |
7,026
+5,165
| +278% | +$628K | 0.6% | 46 |
|
|
2018
Q4 | $215K | Buy |
1,861
+344
| +23% | +$38.4K | 0.16% | 138 |
|
|
2018
Q3 | $163K | Sell |
1,517
-19
| -1% | -$1.9K | 0.1% | 149 |
|
|
2018
Q2 | $131K | Sell |
1,536
-495
| -24% | -$40.7K | 0.09% | 151 |
|
|
2018
Q1 | $154K | Sell |
2,031
-734
| -27% | -$59.1K | 0.11% | 149 |
|
|
2017
Q4 | $234K | Buy |
+2,765
| New | +$235K | 0.18% | 129 |
|
Other funds holding LLY
VCM
VPM
NVWM LLC's LLY Position: Q1 2026 in Review
NVWM LLC increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $55.8K and bringing the position to 3,303 shares worth $3.04M. The position accounts for 0.68% of the portfolio, ranked #36.
NVWM LLC first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.61M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- NVWM LLC held 3,303 shares of Eli Lilly worth $3.04M as of Q1 2026.
- NVWM LLC bought 55 Eli Lilly shares in Q1 2026, an estimated $55.8K.
- Eli Lilly made up 0.68% of NVWM LLC's portfolio in Q1 2026, its #36 holding.
- NVWM LLC first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- NVWM LLC's Eli Lilly position peaked at $4.61M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.